25 XP   0   0   10

Ginkgo Bioworks Holdings
Buy, Hold or Sell?

Let's analyse Ginkgo Bioworks Holdings together

PenkeI guess you are interested in Ginkgo Bioworks Holdings. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Ginkgo Bioworks Holdings. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Ginkgo Bioworks Holdings

I send you an email if I find something interesting about Ginkgo Bioworks Holdings.

Quick analysis of Ginkgo Bioworks Holdings (30 sec.)










What can you expect buying and holding a share of Ginkgo Bioworks Holdings? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
21.4%

What is your share worth?

Current worth
$0.55
Expected worth in 1 year
$0.17
How sure are you?
28.6%

+ What do you gain per year?

Total Gains per Share
$-0.38
Return On Investment
-49.0%

For what price can you sell your share?

Current Price per Share
$0.78
Expected price per share
$0 - $1.03
How sure are you?
50%

1. Valuation of Ginkgo Bioworks Holdings (5 min.)




Live pricePrice per Share (EOD)

$0.78

Intrinsic Value Per Share

$1.68 - $1.98

Total Value Per Share

$2.23 - $2.54

2. Growth of Ginkgo Bioworks Holdings (5 min.)




Is Ginkgo Bioworks Holdings growing?

Current yearPrevious yearGrowGrow %
How rich?$1b$1.5b-$212.3m-15.6%

How much money is Ginkgo Bioworks Holdings making?

Current yearPrevious yearGrowGrow %
Making money-$223.2m-$526.5m$303.3m135.9%
Net Profit Margin-406.2%-500.1%--

How much money comes from the company's main activities?

3. Financial Health of Ginkgo Bioworks Holdings (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#51 / 1010

Most Revenue
#133 / 1010

Most Profit
#1003 / 1010

Most Efficient
#712 / 1010

What can you expect buying and holding a share of Ginkgo Bioworks Holdings? (5 min.)

Welcome investor! Ginkgo Bioworks Holdings's management wants to use your money to grow the business. In return you get a share of Ginkgo Bioworks Holdings.

What can you expect buying and holding a share of Ginkgo Bioworks Holdings?

First you should know what it really means to hold a share of Ginkgo Bioworks Holdings. And how you can make/lose money.

Speculation

The Price per Share of Ginkgo Bioworks Holdings is $0.7777. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Ginkgo Bioworks Holdings.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Ginkgo Bioworks Holdings, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.55. Based on the TTM, the Book Value Change Per Share is $-0.10 per quarter. Based on the YOY, the Book Value Change Per Share is $0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Ginkgo Bioworks Holdings.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.11-13.8%-0.11-14.8%-0.32-40.6%-0.20-26.3%-0.20-26.3%
Usd Book Value Change Per Share-0.09-11.2%-0.10-12.3%0.00-0.4%0.045.1%0.045.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share-0.09-11.2%-0.10-12.2%0.00-0.4%0.045.2%0.045.2%
Usd Price Per Share1.69-1.67-2.81-3.41-3.41-
Price to Earnings Ratio-3.95--3.79--2.66--8.10--8.10-
Price-to-Total Gains Ratio-19.40--19.26--4,059.54--1,281.45--1,281.45-
Price to Book Ratio3.05-2.46-3.03-3.84-3.84-
Price-to-Total Gains Ratio-19.40--19.26--4,059.54--1,281.45--1,281.45-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.7777
Number of shares1285
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.100.04
Usd Total Gains Per Share-0.100.04
Gains per Quarter (1285 shares)-122.3052.36
Gains per Year (1285 shares)-489.20209.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11-490-4996204199
21-980-98812407408
32-1470-147717611617
43-1960-196623815826
54-2450-24552910181035
64-2940-29443512221244
75-3429-34334014261453
86-3919-39224616291662
97-4409-44115218331871
107-4899-49005820372080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%1.013.00.07.1%1.013.00.07.1%1.013.00.07.1%
Book Value Change Per Share0.04.00.00.0%3.08.01.025.0%4.08.02.028.6%4.08.02.028.6%4.08.02.028.6%
Dividend per Share2.00.02.050.0%3.00.09.025.0%3.00.011.021.4%3.00.011.021.4%3.00.011.021.4%
Total Gains per Share0.04.00.00.0%3.08.01.025.0%4.08.02.028.6%4.08.02.028.6%4.08.02.028.6%

Fundamentals of Ginkgo Bioworks Holdings

About Ginkgo Bioworks Holdings

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-04-21 23:06:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Ginkgo Bioworks Holdings.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Ginkgo Bioworks Holdings earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • A Net Profit Margin of -609.1% means that $-6.09 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Ginkgo Bioworks Holdings:

  • The MRQ is -609.1%. The company is making a huge loss. -2
  • The TTM is -406.2%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-609.1%TTM-406.2%-202.9%
TTM-406.2%YOY-500.1%+93.9%
TTM-406.2%5Y-390.5%-15.7%
5Y-390.5%10Y-390.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-609.1%-207.2%-401.9%
TTM-406.2%-216.8%-189.4%
YOY-500.1%-282.3%-217.8%
5Y-390.5%-436.8%+46.3%
10Y-390.5%-597.3%+206.8%
1.1.2. Return on Assets

Shows how efficient Ginkgo Bioworks Holdings is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • -12.7% Return on Assets means that Ginkgo Bioworks Holdings generated $-0.13 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Ginkgo Bioworks Holdings:

  • The MRQ is -12.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -10.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-12.7%TTM-10.9%-1.8%
TTM-10.9%YOY-26.2%+15.3%
TTM-10.9%5Y-17.5%+6.6%
5Y-17.5%10Y-17.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.7%-13.3%+0.6%
TTM-10.9%-12.8%+1.9%
YOY-26.2%-11.6%-14.6%
5Y-17.5%-13.8%-3.7%
10Y-17.5%-15.6%-1.9%
1.1.3. Return on Equity

Shows how efficient Ginkgo Bioworks Holdings is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • -19.3% Return on Equity means Ginkgo Bioworks Holdings generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Ginkgo Bioworks Holdings:

  • The MRQ is -19.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.3%TTM-16.9%-2.4%
TTM-16.9%YOY-34.9%+18.0%
TTM-16.9%5Y-205.8%+188.8%
5Y-205.8%10Y-205.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.3%-16.9%-2.4%
TTM-16.9%-16.1%-0.8%
YOY-34.9%-14.9%-20.0%
5Y-205.8%-19.3%-186.5%
10Y-205.8%-20.1%-185.7%

1.2. Operating Efficiency of Ginkgo Bioworks Holdings.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Ginkgo Bioworks Holdings is operating .

  • Measures how much profit Ginkgo Bioworks Holdings makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • An Operating Margin of -444.4% means the company generated $-4.44  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Ginkgo Bioworks Holdings:

  • The MRQ is -444.4%. The company is operating very inefficient. -2
  • The TTM is -259.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-444.4%TTM-259.9%-184.5%
TTM-259.9%YOY-517.5%+257.6%
TTM-259.9%5Y-365.5%+105.6%
5Y-365.5%10Y-365.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-444.4%-298.0%-146.4%
TTM-259.9%-238.5%-21.4%
YOY-517.5%-288.4%-229.1%
5Y-365.5%-486.2%+120.7%
10Y-365.5%-628.4%+262.9%
1.2.2. Operating Ratio

Measures how efficient Ginkgo Bioworks Holdings is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 5.44 means that the operating costs are $5.44 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Ginkgo Bioworks Holdings:

  • The MRQ is 5.444. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.209. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.444TTM4.209+1.236
TTM4.209YOY6.201-1.993
TTM4.2095Y4.738-0.529
5Y4.73810Y4.7380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.4443.235+2.209
TTM4.2093.310+0.899
YOY6.2013.838+2.363
5Y4.7385.679-0.941
10Y4.7387.823-3.085

1.3. Liquidity of Ginkgo Bioworks Holdings.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Ginkgo Bioworks Holdings is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.11 means the company has $6.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Ginkgo Bioworks Holdings:

  • The MRQ is 6.113. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.826. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.113TTM6.826-0.713
TTM6.826YOY11.181-4.355
TTM6.8265Y8.071-1.245
5Y8.07110Y8.0710.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1133.863+2.250
TTM6.8264.169+2.657
YOY11.1815.337+5.844
5Y8.0716.122+1.949
10Y8.0716.434+1.637
1.3.2. Quick Ratio

Measures if Ginkgo Bioworks Holdings is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • A Quick Ratio of 5.98 means the company can pay off $5.98 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Ginkgo Bioworks Holdings:

  • The MRQ is 5.984. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.627. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.984TTM6.627-0.643
TTM6.627YOY10.846-4.219
TTM6.6275Y235.838-229.211
5Y235.83810Y235.8380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.9843.504+2.480
TTM6.6273.991+2.636
YOY10.8465.371+5.475
5Y235.8386.088+229.750
10Y235.8386.395+229.443

1.4. Solvency of Ginkgo Bioworks Holdings.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Ginkgo Bioworks Holdings assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Ginkgo Bioworks Holdings to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.34 means that Ginkgo Bioworks Holdings assets are financed with 34.1% credit (debt) and the remaining percentage (100% - 34.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Ginkgo Bioworks Holdings:

  • The MRQ is 0.341. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.350. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.341TTM0.350-0.009
TTM0.350YOY0.251+0.099
TTM0.3505Y0.245+0.105
5Y0.24510Y0.2450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3410.339+0.002
TTM0.3500.337+0.013
YOY0.2510.271-0.020
5Y0.2450.368-0.123
10Y0.2450.388-0.143
1.4.2. Debt to Equity Ratio

Measures if Ginkgo Bioworks Holdings is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • A Debt to Equity ratio of 51.8% means that company has $0.52 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Ginkgo Bioworks Holdings:

  • The MRQ is 0.518. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.541. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.518TTM0.541-0.023
TTM0.541YOY0.344+0.197
TTM0.5415Y6.120-5.579
5Y6.12010Y6.1200.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5180.392+0.126
TTM0.5410.403+0.138
YOY0.3440.335+0.009
5Y6.1200.427+5.693
10Y6.1200.461+5.659

2. Market Valuation of Ginkgo Bioworks Holdings

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Ginkgo Bioworks Holdings generates.

  • Above 15 is considered overpriced but always compare Ginkgo Bioworks Holdings to the Biotechnology industry mean.
  • A PE ratio of -3.95 means the investor is paying $-3.95 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Ginkgo Bioworks Holdings:

  • The EOD is -1.816. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.947. Based on the earnings, the company is expensive. -2
  • The TTM is -3.790. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.816MRQ-3.947+2.131
MRQ-3.947TTM-3.790-0.158
TTM-3.790YOY-2.662-1.127
TTM-3.7905Y-8.101+4.311
5Y-8.10110Y-8.1010.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.816-2.300+0.484
MRQ-3.947-2.656-1.291
TTM-3.790-2.718-1.072
YOY-2.662-4.145+1.483
5Y-8.101-6.258-1.843
10Y-8.101-6.315-1.786
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Ginkgo Bioworks Holdings:

  • The EOD is -7.395. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -16.069. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.879. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.395MRQ-16.069+8.674
MRQ-16.069TTM-10.879-5.190
TTM-10.879YOY-18.254+7.375
TTM-10.8795Y-29.991+19.113
5Y-29.99110Y-29.9910.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-7.395-2.974-4.421
MRQ-16.069-3.306-12.763
TTM-10.879-3.508-7.371
YOY-18.254-5.613-12.641
5Y-29.991-8.378-21.613
10Y-29.991-8.873-21.118
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Ginkgo Bioworks Holdings is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.05 means the investor is paying $3.05 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Ginkgo Bioworks Holdings:

  • The EOD is 1.402. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.046. Based on the equity, the company is fair priced.
  • The TTM is 2.461. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.402MRQ3.046-1.644
MRQ3.046TTM2.461+0.586
TTM2.461YOY3.034-0.573
TTM2.4615Y3.838-1.378
5Y3.83810Y3.8380.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.4021.914-0.512
MRQ3.0462.116+0.930
TTM2.4612.097+0.364
YOY3.0342.881+0.153
5Y3.8383.550+0.288
10Y3.8383.936-0.098
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Ginkgo Bioworks Holdings.

3.1. Institutions holding Ginkgo Bioworks Holdings

Institutions are holding 83.304% of the shares of Ginkgo Bioworks Holdings.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Baillie Gifford & Co Limited.10.97810.3165236292183-2516640-1.0538
2023-12-31ARK Investment Management LLC9.22721.9871198606619164144349.0094
2023-12-31Viking Global Investors LP6.64770.885714308512600
2023-12-31Vanguard Group Inc6.16890.00491327800954630960.35
2023-12-31BlackRock Inc3.3820.003172794866955990.1315
2023-12-31Anchorage Advisors, LLC3.245414.04966985459300
2023-12-31Nikko Asset Management Americas Inc2.70580.940558238915-507245-0.8635
2023-12-31Sumitomo Mitsui Trust Holdings Inc2.70580.072858238915-507245-0.8635
2023-12-31Morgan Stanley - Brokerage Accounts2.27480.007348962819-804601-1.6167
2023-12-31State Street Corporation1.21040.002126053646359991016.0326
2023-12-31SB INVESTMENT ADVISERS (UK) LTD1.1350.36752442919100
2023-12-31Geode Capital Management, LLC0.97970.00372108785110492105.2359
2023-12-31NORGES BANK0.68640.004414773078689942687.6268
2023-12-31Millennium Management LLC0.43050.0068926640428430.0307
2023-12-31Exor Investments (UK) LLP0.39540.69248511301220000034.8581
2023-12-31Charles Schwab Investment Management Inc0.35590.003376613032429063.2744
2023-12-31Welch & Forbes LLC0.32520.1787700000000
2023-12-31Northern Trust Corp0.28550.001961456911957083.2892
2023-09-30Citadel Advisors Llc0.24360.00252432354209939407.4282
2023-12-31Susquehanna International Group, LLP0.22540.00164850681192322265.6959
Total 53.608719.53191153876512+32960562+2.9%

3.2. Funds holding Ginkgo Bioworks Holdings

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-03-31ARK Innovation ETF5.7711.853612421401900
2024-03-31ARK Disruptive Innovation Full Composite5.75611.8509123893747-5054858-3.9201
2024-02-29Scottish Mortgage Ord5.55650.80951195982155330412180.4055
2024-03-31ARK Genomic Revolution2.43773.787252469430-5386625-9.3104
2024-03-31ARK Genomic Revolution ETF2.43123.78895232875100
2024-02-29Vanguard Total Stock Mkt Idx Inv2.10960.004545407644-153812-0.3376
2024-03-31Vanguard Small Cap Index1.63410.027735172073-2398536-6.3841
2024-02-29Nikko AM ARK Disruptive Innovation A USD1.62861.722235054351-547618-1.5382
2024-03-31Vanguard Institutional Extnd Mkt Idx Tr0.93390.0222201020772686691.3546
2024-03-31Vanguard Small Cap Growth Index Inv0.92370.063519882306-1203136-5.706
2024-02-29Baillie Gifford US Equity Growth0.86560.34031863194800
2023-12-31Vanguard US Growth Investor0.86560.07871863194800
2024-02-29Nikko AM ARK Pstv Chg Innovt P JPY Acc0.78111.014116813087-149732-0.8827
2023-12-31Morgan Stanley Growth0.53610.35141154001000
2023-12-31Morgan Stanley Growth SMA0.53610.35141154001000
2023-12-31Morgan Stanley Inst Growth I0.53610.35111154001000
2024-03-28iShares Biotechnology ETF0.45930.15039884941-79453-0.7974
2024-03-28L&G Artificial Intelligence ETF0.44921.619966892700
2024-03-31State St Russell Sm/Mid Cp® Indx NL Cl C0.44660.025896122351422001.5016
2024-02-29Baillie Gifford WW L/T Glb Gr B USD Acc0.41590.35588952214-171918-1.8842
Total 35.07418.5681754937943+38569302+5.1%

3.3. Insider Transactions

Insiders are holding 6.74% of the shares of Ginkgo Bioworks Holdings.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-04-02Mark E DmytrukSELL511691.05
2024-02-02Mark E DmytrukSELL395691.21
2024-01-03Jason R KellySELL1000001.54
2023-12-20Barry CantonSELL376501.79
2023-12-20Jason R KellySELL1000001.79
2023-12-13Barry CantonSELL368291.34
2023-12-13Jason R KellySELL990201.34
2023-12-06Barry CantonSELL376501.32
2023-12-06Jason R KellySELL1000001.32
2023-12-04Mark E DmytrukSELL424021.39
2023-11-29Reshma P ShettySELL376501.45
2023-11-24Barry CantonSELL376501.42
2023-11-24Jason R KellySELL1000001.41
2023-11-22Barry CantonSELL376501.4
2023-11-22Jason R KellySELL1000001.4
2023-11-15Barry CantonSELL376501.54
2023-11-15Jason R KellySELL1000001.54
2023-11-08Reshma P ShettySELL376501.5
2023-11-02Christian O HenrySELL45001.39
2023-11-01Reshma P ShettySELL376501.34

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Ginkgo Bioworks Holdings compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.087-0.095+9%-0.003-96%0.040-320%0.040-320%
Book Value Per Share--0.5550.703-21%0.927-40%0.756-27%0.756-27%
Current Ratio--6.1136.826-10%11.181-45%8.071-24%8.071-24%
Debt To Asset Ratio--0.3410.350-3%0.251+36%0.245+39%0.245+39%
Debt To Equity Ratio--0.5180.541-4%0.344+51%6.120-92%6.120-92%
Dividend Per Share--0.0000.000+98%-+100%0.001-75%0.001-75%
Eps---0.107-0.115+7%-0.316+195%-0.204+91%-0.204+91%
Free Cash Flow Per Share---0.026-0.042+60%0.159-117%0.014-292%0.014-292%
Free Cash Flow To Equity Per Share---0.031-0.044+40%0.172-118%0.084-137%0.084-137%
Gross Profit Margin--0.8880.972-9%1.000-11%0.992-10%0.992-10%
Intrinsic Value_10Y_max--1.984--------
Intrinsic Value_10Y_min--1.679--------
Intrinsic Value_1Y_max--0.106--------
Intrinsic Value_1Y_min--0.105--------
Intrinsic Value_3Y_max--0.390--------
Intrinsic Value_3Y_min--0.371--------
Intrinsic Value_5Y_max--0.759--------
Intrinsic Value_5Y_min--0.698--------
Market Cap1283912669.670-160%3342326520.0003254654972.500+3%4717010016.288-29%5798773651.562-42%5798773651.562-42%
Net Profit Margin---6.091-4.062-33%-5.001-18%-3.905-36%-3.905-36%
Operating Margin---4.444-2.599-42%-5.175+16%-3.655-18%-3.655-18%
Operating Ratio--5.4444.209+29%6.201-12%4.738+15%4.738+15%
Pb Ratio1.402-117%3.0462.461+24%3.034+0%3.838-21%3.838-21%
Pe Ratio-1.816+54%-3.947-3.790-4%-2.662-33%-8.101+105%-8.101+105%
Price Per Share0.778-117%1.6901.673+1%2.805-40%3.412-50%3.412-50%
Price To Free Cash Flow Ratio-7.395+54%-16.069-10.879-32%-18.254+14%-29.991+87%-29.991+87%
Price To Total Gains Ratio-8.929+54%-19.404-19.257-1%-4059.541+20821%-1281.448+6504%-1281.448+6504%
Quick Ratio--5.9846.627-10%10.846-45%235.838-97%235.838-97%
Return On Assets---0.127-0.109-14%-0.262+106%-0.175+38%-0.175+38%
Return On Equity---0.193-0.169-12%-0.349+81%-2.058+966%-2.058+966%
Total Gains Per Share---0.087-0.095+9%-0.003-96%0.041-314%0.041-314%
Usd Book Value--1097152000.0001365251500.000-20%1577612000.000-30%1319698825.929-17%1319698825.929-17%
Usd Book Value Change Per Share---0.087-0.095+9%-0.003-96%0.040-320%0.040-320%
Usd Book Value Per Share--0.5550.703-21%0.927-40%0.756-27%0.756-27%
Usd Dividend Per Share--0.0000.000+98%-+100%0.001-75%0.001-75%
Usd Eps---0.107-0.115+7%-0.316+195%-0.204+91%-0.204+91%
Usd Free Cash Flow---52000000.000-81756000.000+57%258845250.000-120%18114142.857-387%18114142.857-387%
Usd Free Cash Flow Per Share---0.026-0.042+60%0.159-117%0.014-292%0.014-292%
Usd Free Cash Flow To Equity Per Share---0.031-0.044+40%0.172-118%0.084-137%0.084-137%
Usd Market Cap1283912669.670-160%3342326520.0003254654972.500+3%4717010016.288-29%5798773651.562-42%5798773651.562-42%
Usd Price Per Share0.778-117%1.6901.673+1%2.805-40%3.412-50%3.412-50%
Usd Profit---211694000.000-223217250.000+5%-526593000.000+149%-350161928.571+65%-350161928.571+65%
Usd Revenue--34755000.00062863750.000-45%119426500.000-71%77739857.143-55%77739857.143-55%
Usd Total Gains Per Share---0.087-0.095+9%-0.003-96%0.041-314%0.041-314%
 EOD+3 -5MRQTTM+21 -15YOY+12 -245Y+9 -2710Y+9 -27

4.2. Fundamental Score

Let's check the fundamental score of Ginkgo Bioworks Holdings based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.816
Price to Book Ratio (EOD)Between0-11.402
Net Profit Margin (MRQ)Greater than0-6.091
Operating Margin (MRQ)Greater than0-4.444
Quick Ratio (MRQ)Greater than15.984
Current Ratio (MRQ)Greater than16.113
Debt to Asset Ratio (MRQ)Less than10.341
Debt to Equity Ratio (MRQ)Less than10.518
Return on Equity (MRQ)Greater than0.15-0.193
Return on Assets (MRQ)Greater than0.05-0.127
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Ginkgo Bioworks Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.917
Ma 20Greater thanMa 500.994
Ma 50Greater thanMa 1001.150
Ma 100Greater thanMa 2001.287
OpenGreater thanClose0.821
Total1/5 (20.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Accumulated Other Comprehensive Income  -2,6321,018-1,614314-1,300-1,599-2,8994,3831,484



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,665,342
Total Liabilities568,190
Total Stockholder Equity1,097,152
 As reported
Total Liabilities 568,190
Total Stockholder Equity+ 1,097,152
Total Assets = 1,665,342

Assets

Total Assets1,665,342
Total Current Assets1,001,749
Long-term Assets663,593
Total Current Assets
Cash And Cash Equivalents 948,862
Net Receivables 31,738
Inventory 46
Other Current Assets 21,103
Total Current Assets  (as reported)1,001,749
Total Current Assets  (calculated)1,001,749
+/-0
Long-term Assets
Property Plant Equipment 397,224
Goodwill 49,238
Long Term Investments 77,911
Intangible Assets 82,741
Long-term Assets Other 1,502
Long-term Assets  (as reported)663,593
Long-term Assets  (calculated)608,616
+/- 54,977

Liabilities & Shareholders' Equity

Total Current Liabilities163,860
Long-term Liabilities404,330
Total Stockholder Equity1,097,152
Total Current Liabilities
Short-term Debt 19,933
Accounts payable 9,323
Other Current Liabilities 86,109
Total Current Liabilities  (as reported)163,860
Total Current Liabilities  (calculated)115,365
+/- 48,495
Long-term Liabilities
Capital Lease Obligations 241,768
Long-term Liabilities Other 18,733
Long-term Liabilities  (as reported)404,330
Long-term Liabilities  (calculated)260,501
+/- 143,829
Total Stockholder Equity
Common Stock199
Retained Earnings -5,290,528
Accumulated Other Comprehensive Income 1,484
Other Stockholders Equity 6,385,997
Total Stockholder Equity (as reported)1,097,152
Total Stockholder Equity (calculated)1,097,152
+/-0
Other
Capital Stock199
Cash and Short Term Investments 948,862
Common Stock Shares Outstanding 1,977,708
Current Deferred Revenue48,495
Liabilities and Stockholders Equity 1,665,342
Net Debt -707,094
Net Invested Capital 1,097,152
Net Working Capital 837,889
Property Plant and Equipment Gross 517,942
Short Long Term Debt Total 241,768



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-03-31
> Total Assets 
0
0
675,153
1,728,031
1,725,988
2,150,591
2,070,990
2,070,990
1,994,219
1,870,695
2,539,321
2,417,209
2,291,999
2,026,392
1,665,342
1,665,3422,026,3922,291,9992,417,2092,539,3211,870,6951,994,2192,070,9902,070,9902,150,5911,725,9881,728,031675,15300
   > Total Current Assets 
0
0
426,542
2,986
967
1,810,569
1,723,045
1,723,045
1,598,848
1,462,003
1,450,079
1,327,306
1,223,453
1,141,846
1,001,749
1,001,7491,141,8461,223,4531,327,3061,450,0791,462,0031,598,8481,723,0451,723,0451,810,5699672,986426,54200
       Cash And Cash Equivalents 
0
0
380,801
1,917
38
1,739,056
1,550,004
1,550,004
1,377,152
1,302,603
1,315,792
1,206,086
1,105,787
1,049,244
948,862
948,8621,049,2441,105,7871,206,0861,315,7921,302,6031,377,1521,550,0041,550,0041,739,056381,917380,80100
       Short-term Investments 
0
0
0
1,725,045
1,725,021
0
0
0
0
-4,463
0
0
-25
-643
0
0-643-2500-4,46300001,725,0211,725,045000
       Net Receivables 
0
0
24,935
33,454
31,480
50,725
149,899
131,544
174,877
115,756
82,465
84,841
68,918
63,143
31,738
31,73863,14368,91884,84182,465115,756174,877131,544149,89950,72531,48033,45424,93500
       Other Current Assets 
0
0
680
1,069
929
17,314
698
38,135
38,717
37,784
47,458
33,870
48,357
29,389
21,103
21,10329,38948,35733,87047,45837,78438,71738,13569817,3149291,06968000
   > Long-term Assets 
0
0
248,611
1,725,045
1,725,021
340,022
347,945
347,945
395,371
408,692
1,089,242
1,089,903
1,068,546
884,546
663,593
663,593884,5461,068,5461,089,9031,089,242408,692395,371347,945347,945340,0221,725,0211,725,045248,61100
       Property Plant Equipment 
0
0
121,435
141,919
145,884
142,704
145,770
145,770
176,221
187,577
715,535
702,243
685,674
543,209
397,224
397,224543,209685,674702,243715,535187,577176,221145,770145,770142,704145,884141,919121,43500
       Goodwill 
0
0
1,857
0
1,857
16,660
21,312
21,312
30,973
28,804
60,210
58,725
58,829
58,057
49,238
49,23858,05758,82958,72560,21028,80430,97321,31221,31216,6601,85701,85700
       Long Term Investments 
0
0
0
0
0
104,771
102,037
103,031
89,068
96,310
113,731
121,750
119,969
85,613
77,911
77,91185,613119,969121,750113,73196,31089,068103,031102,037104,77100000
       Intangible Assets 
0
0
3,294
0
3,020
22,568
21,642
21,642
39,180
47,938
111,041
108,736
105,033
100,168
82,741
82,741100,168105,033108,736111,04147,93839,18021,64221,64222,5683,02003,29400
       Other Assets 
0
0
0
22,652
42,092
36,962
43,990
49,616
53,015
43,928
88,725
97,262
97,946
97,022
0
097,02297,94697,26288,72543,92853,01549,61643,99036,96242,09222,652000
> Total Liabilities 
0
0
205,101
150,139
254,952
532,620
503,611
503,611
427,163
430,959
803,044
809,623
788,414
773,709
568,190
568,190773,709788,414809,623803,044430,959427,163503,611503,611532,620254,952150,139205,10100
   > Total Current Liabilities 
0
0
73,221
1,422
4,689
90,305
134,761
134,761
135,022
124,818
172,962
191,704
163,331
168,462
163,860
163,860168,462163,331191,704172,962124,818135,022134,761134,76190,3054,6891,42273,22100
       Short-term Debt 
0
0
485
0
0
0
747
0
0
0
29,332
0
0
0
19,933
19,93300029,33200074700048500
       Accounts payable 
0
0
13,893
1,422
4,689
7,102
8,189
8,189
19,459
11,323
10,451
21,571
13,630
10,753
9,323
9,32310,75313,63021,57110,45111,32319,4598,1898,1897,1024,6891,42213,89300
       Other Current Liabilities 
0
0
30,020
1,422
4,689
53,554
92,585
93,332
70,059
72,990
85,362
122,615
110,478
114,947
86,109
86,109114,947110,478122,61585,36272,99070,05993,33292,58553,5544,6891,42230,02000
   > Long-term Liabilities 
0
0
131,880
148,718
250,263
442,315
368,850
368,850
292,141
306,141
630,082
617,919
625,083
605,247
404,330
404,330605,247625,083617,919630,082306,141292,141368,850368,850442,315250,263148,718131,88000
       Long term Debt Total 
0
0
0
0
16,358
16,268
22,283
27,309
51,545
59,842
0
0
0
0
0
0000059,84251,54527,30922,28316,26816,3580000
       Warrants
0
0
0
1,572,791
1,466,036
0
0
0
0
0
0
0
0
0
0
00000000001,466,0361,572,791000
       Other Liabilities 
0
0
0
132,480
133,810
426,047
346,567
257,122
240,596
246,299
216,826
0
214,145
201,585
0
0201,585214,1450216,826246,299240,596257,122346,567426,047133,810132,480000
       Deferred Long Term Liability 
0
0
0
60,375
60,375
180,002
174,737
189,438
177,195
171,638
174,767
174,815
0
0
0
000174,815174,767171,638177,195189,438174,737180,00260,37560,375000
> Total Stockholder Equity
0
0
461,376
5,000
5,000
1,551,551
1,505,365
1,505,365
1,535,431
1,434,736
1,736,277
1,607,586
1,503,585
1,252,683
1,097,152
1,097,1521,252,6831,503,5851,607,5861,736,2771,434,7361,535,4311,505,3651,505,3651,551,5515,0005,000461,37600
   Common Stock
0
0
129
1,572,797
1,466,043
148
161
161
164
165
190
194
196
198
199
1991981961941901651641611611481,466,0431,572,79712900
   Retained Earnings Total Equity
0
0
0
4,994
-100,999
-697,269
-2,297,925
-2,888,430
-3,557,255
-4,226,310
-4,397,659
-4,602,628
0
0
0
000-4,602,628-4,397,659-4,226,310-3,557,255-2,888,430-2,297,925-697,269-100,9994,994000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
-877
-1,715
-2,355
-5,496
-7,910
-2,632
-1,614
-1,300
-2,899
1,484
1,484-2,899-1,300-1,614-2,632-7,910-5,496-2,355-1,715-87700000
   Capital Surplus 
0
0
0
0
105,992
2,249,549
3,804,844
4,471,418
5,098,018
5,668,791
6,136,378
6,211,634
6,280,632
6,334,218
0
06,334,2186,280,6326,211,6346,136,3785,668,7915,098,0184,471,4183,804,8442,249,549105,9920000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
929,125
-1,572,791
-1,360,045
2,315,969
3,804,844
3,803,129
5,098,018
5,668,791
6,136,378
6,211,634
6,280,632
6,334,218
6,385,997
6,385,9976,334,2186,280,6326,211,6346,136,3785,668,7915,098,0183,803,1293,804,8442,315,969-1,360,045-1,572,791929,12500



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue251,455
Cost of Revenue-108,812
Gross Profit142,643142,643
 
Operating Income (+$)
Gross Profit142,643
Operating Expense-814,874
Operating Income-672,231-672,231
 
Operating Expense (+$)
Research Development525,814
Selling General Administrative385,025
Selling And Marketing Expenses-95,965
Operating Expense814,874814,874
 
Net Interest Income (+$)
Interest Income57,217
Interest Expense-93
Other Finance Cost-1,875
Net Interest Income55,249
 
Pretax Income (+$)
Operating Income-672,231
Net Interest Income55,249
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-892,940-451,522
EBIT - interestExpense = -672,324
-892,940
-892,776
Interest Expense93
Earnings Before Interest and Taxes (EBIT)-672,231-892,847
Earnings Before Interest and Taxes (EBITDA)-600,677
 
After tax Income (+$)
Income Before Tax-892,940
Tax Provision--14,643
Net Income From Continuing Ops-854,253-878,297
Net Income-892,869
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses923,686
Total Other Income/Expenses Net-220,709-55,249
 

Technical Analysis of Ginkgo Bioworks Holdings
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Ginkgo Bioworks Holdings. The general trend of Ginkgo Bioworks Holdings is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Ginkgo Bioworks Holdings's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Ginkgo Bioworks Holdings.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.03 < 1.03 < 1.03.

The bearish price targets are: .

Tweet this
Ginkgo Bioworks Holdings Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Ginkgo Bioworks Holdings. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Ginkgo Bioworks Holdings Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Ginkgo Bioworks Holdings. The current macd is -0.09119974.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ginkgo Bioworks Holdings price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Ginkgo Bioworks Holdings. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Ginkgo Bioworks Holdings price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Ginkgo Bioworks Holdings Daily Moving Average Convergence/Divergence (MACD) ChartGinkgo Bioworks Holdings Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Ginkgo Bioworks Holdings. The current adx is 23.45.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Ginkgo Bioworks Holdings shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Ginkgo Bioworks Holdings Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Ginkgo Bioworks Holdings. The current sar is 1.01274416.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Ginkgo Bioworks Holdings Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Ginkgo Bioworks Holdings. The current rsi is 29.92. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Ginkgo Bioworks Holdings Daily Relative Strength Index (RSI) ChartGinkgo Bioworks Holdings Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Ginkgo Bioworks Holdings. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Ginkgo Bioworks Holdings price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Ginkgo Bioworks Holdings Daily Stochastic Oscillator ChartGinkgo Bioworks Holdings Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Ginkgo Bioworks Holdings. The current cci is -137.80546739.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Ginkgo Bioworks Holdings Daily Commodity Channel Index (CCI) ChartGinkgo Bioworks Holdings Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Ginkgo Bioworks Holdings. The current cmo is -48.9756699.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Ginkgo Bioworks Holdings Daily Chande Momentum Oscillator (CMO) ChartGinkgo Bioworks Holdings Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Ginkgo Bioworks Holdings. The current willr is -91.68334445.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Ginkgo Bioworks Holdings Daily Williams %R ChartGinkgo Bioworks Holdings Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Ginkgo Bioworks Holdings.

Ginkgo Bioworks Holdings Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Ginkgo Bioworks Holdings. The current atr is 0.08611947.

Ginkgo Bioworks Holdings Daily Average True Range (ATR) ChartGinkgo Bioworks Holdings Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Ginkgo Bioworks Holdings. The current obv is -456,218,493.

Ginkgo Bioworks Holdings Daily On-Balance Volume (OBV) ChartGinkgo Bioworks Holdings Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Ginkgo Bioworks Holdings. The current mfi is 25.15.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Ginkgo Bioworks Holdings Daily Money Flow Index (MFI) ChartGinkgo Bioworks Holdings Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Ginkgo Bioworks Holdings.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-09CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-01CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Ginkgo Bioworks Holdings Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Ginkgo Bioworks Holdings based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5029.917
Ma 20Greater thanMa 500.994
Ma 50Greater thanMa 1001.150
Ma 100Greater thanMa 2001.287
OpenGreater thanClose0.821
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Ginkgo Bioworks Holdings with someone you think should read this too:
  • Are you bullish or bearish on Ginkgo Bioworks Holdings? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Ginkgo Bioworks Holdings? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Ginkgo Bioworks Holdings

I send you an email if I find something interesting about Ginkgo Bioworks Holdings.


Comments

How you think about this?

Leave a comment

Stay informed about Ginkgo Bioworks Holdings.

Receive notifications about Ginkgo Bioworks Holdings in your mailbox!